POMC Deficiency
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Early Genetic Identification of Obesity (NCT06239064) | Rolfs Consulting und Verwaltungs-GmbH (RCV) | 2024-01-24 |
| Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway (NCT05194124) | Rhythm Pharmaceuticals, Inc. | 2021-12-21 |
Track POMC Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.